[Prevention and treatment of osteoporosis during treatment of non-metastatic prostate cancer]. / Udredning og behandling af osteoporose hos patienter med prostatacancer uden knoglemetastaser.
Ugeskr Laeger
; 173(48): 3093-6, 2011 Nov 28.
Article
en Da
| MEDLINE
| ID: mdl-22118650
ABSTRACT
The prevention of cancer treatment-induced bone loss in patients with prostate cancer due to gonadotropin-releasing hormone (GnRH)-agonist, GnRH-antagonist and orchidectomi therapy has a high priority. We present an algorithm for the prevention and treatment of osteoporosis during treatment of non-metastatic prostate cancer.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
1_ASSA2030
/
2_ODS3
Problema de salud:
1_doencas_nao_transmissiveis
/
2_muertes_prematuras_enfermedades_notrasmisibles
Asunto principal:
Osteoporosis
/
Neoplasias de la Próstata
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Guideline
/
Risk_factors_studies
Límite:
Humans
/
Male
Idioma:
Da
Revista:
Ugeskr Laeger
Año:
2011
Tipo del documento:
Article
País de afiliación:
Dinamarca